Revision surgery versus biologic treatment with omalizumab in recurrent chronic rhinosinusitis with nasal polyps: An analysis of cost-utility and clinical outcomes by Yutong Sima, MS, Jing Zhang, MS, Ming Zheng, MD, Yan Zhao, PhD, Xiangdong Wang, MD, PhD, Luo Zhang, MD, PhD

Subjects: “…Recurrent chronic rhinosinusitis with nasal polyps…”
Get full text